Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis

Receiving a platform technology designation from the FDA is a tremendous milestone for our development team and Krystal, both as recognition of the reproducibility and scalability of our HSV-1 gene ...
Nature

Nerve Growth Factor and Reproductive Physiology

Nerve Growth Factor (NGF) has long been recognised for its critical role in neural development. Recently, however, its influence in reproductive physiology has attracted significant attention.

Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain

ZTS secures CVMP's positive opinion recommending the approval of Lenivia, a long-acting OA pain therapy for dogs, with the ...

Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs

Zoetis Inc. today announced that Health Canada has approved Lenivia ® (izenivetmab injection) for the alleviation of pain associated with osteoarthritis (OA) in dogs. Built on a decade of science and ...
Acsh.org

Great Women of Science: Rita Levi-Montalcini, Nobelist & Stateswoman

Before chronic pain research had a name for its nemesis, Dr. Levi-Montalcini discovered the molecule that would revolutionize its treatment: Nerve Growth Factor. Exiled, underestimated, and elegant to ...

Zoetis Inc.: Zoetis Receives Positive Opinion from CVMP for Lenivia (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

Zoetis Inc. today announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of marketing ...